N-methyl-2-pyrrolidone - Occupational-medical importance and toxicology;N-methyl-2-pyrrolidon - Arbeitsmedizinische bedeutung und toxikologie

Arbeitsmedizin Sozialmedizin Umweltmedizin

Volumn 37, Issue 9, 2002, Pages 422-428

  Bader, M ^a   Will, W ^a   Rossbacher, R ^a   Nasterlack, M ^a   Wrbitzky, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biomonitoring; Dermal absorption; N Methyl 2 pyrrolidone; Organic solvents

Indexed keywords

1 METHYL 2 PYRROLIDINONE; SOLVENT;

BIOLOGICAL MONITORING; BLOOD LEVEL; CARCINOGENICITY; CHEMICAL STRUCTURE; EMBRYOTOXICITY; EVALUATION; EYE TOXICITY; HUMAN; LIVER CARCINOGENESIS; LIVER TUMOR; LONG TERM EXPOSURE; LUNG TOXICITY; METABOLITE; NONHUMAN; RAT; RELIABILITY; REVIEW; SKIN ABSORPTION; SKIN TOXICITY; TOXICITY TESTING; TOXICOKINETICS; URINE LEVEL;

EID: 0036736282     PISSN: 09446052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Åkesson, B., B. A. G. Jönsson: Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker. Scand. J. Work Environ. Health 26 (2000) 213-218
2. Åkesson, B., B. A. G. Jönsson: Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab. Dispos. 25 (1997) 267-269
3. Åkesson, B., K. Paulsson: Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup. Environ. Med. 54 (1997) 236-240
4. Anundi, H., M. L. Lind, L. Friis, N. Itkes, S. Langworth, C. Edling: High exposures to organic solvents among graffiti removers. Int. Arch. Occup. Environ. Health 65 (1993) 247-251
5. Anundi, H., S. Langworth, G. Johanson, M. L. Lind, B. Åkesson, L. Friis, N. Itkes, E. Söderman, B. A. G. Jönsson, C. Edling: Air and biological monitoring of solvent exposure during graffiti removal. Int. Arch. Occup. Environ. Health 73 (2000) 561-569
6. Barry, B. W., D. Southwell, R. Woodford: Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. J. Invest. Dermatol. 82 (1984) 49-52
7. BASF: Abteilung Toxikologie, unveröffentlichte Untersuchungen (ZST Nr. 90/544) 90 Tage Inhalationsstudie Ratte (1994)
8. BASF: Bericht über die Prüfung der Toxizität von N-Methyl-pyrrolidon im 4-Wochen-Sondierungsversuch an der Ratte. Unveröffentlichte Untersuchung vom 22. 5. 1978, zitiert nach Greim und Lehnert (Hrsg.) 1994
9. BASF: Abteilung Toxikologie, unveröffentlichte Untersuchungen (Projekt Nr. 44R0544/90078) Teratogenitätsstudie an Kaninchen mit dermaler Applikation (1993a)
10. BASF: Abteilung Toxikologie, unveröffentlichte Untersuchungen (Projekt Nr. 41R0544/90100) Teratogenitätsstudie an Kaninchen mit inhalativer Exposition (1993b)
11. BASF: Abteilung Toxikologie, unveröffentlichte Untersuchungen (Projekt Nr. 76C0225/93065) Kanzerogenitätsstudie an der Maus - Verabreichung über das Futter (1999)
12. BASF: Abteilung Toxikologie, unveröffentlichte Untersuchungen (Projekt Nr. 70R0056/97008) Mehrgenerationsstudie Ratte - Verabreichung über das Futter (1999a)
13. BASF: persönliche Mitteilung "Produktionskapazitäten NMP" vom 15. 3. 2002
14. Becchi, P. J., L. A. Gephart, F. J. Koschier, W. D. Johnson, L. W. Burnette: Subchronic feeding study in beagle dogs of N-methyl-pyrrolidone. J. Appl. Toxicol. 3 (1983) 83-86
15. Becchi, P. J., M. J. Knickerbocker, E. L. Reagan, R. A. Parent: Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats. Fundam. Appl. Toxicol. 2 (1982) 73-76
16. Beyer, B. K. (Study Director) Final report: Developmental toxicity study in rats with N-methylpyrrolidone. Exxon Biomedical Services, Inc., East Millstone, NJ., Project No. 136534, dated June 5, 1992 (for GAF Corporation, Wayne, NJ)
17. BNA (Bureau of National Affairs) Occup. Safety Health Rep. 11 (1993) 790-791
18. Bower, D. B.: Stillbirth after occupational exposure to N-methyl-2-pyrrolidone. Letter to the editor. J. Occup. Environ. Med. 39 (1997) 393
19. Bundesarbeitsblatt: TRGS 150. Unmittelbarer Hautkontakt mit Gefahrstoffen, die durch die Haut resorbiert werden können - Hautresorbierbare Gefahrstoffe. BArbBI 6 (1996) 31-33
20. Bundesarbeitsblatt: TRGS 612. Ersatzstoffe, Ersatzverfahren und Verwendungsbeschrankungen für Dichlormethan beim Einsatz in Abbeizmitteln. BArbBI 3 (1998) 50-52
21. Bundesarbeitsblatt: TRGS 710. Biomonitoring. BArbBI. 2 (2000) 60-62
22. E. I. du Pont de Nemours and company, unpublished data for the NMP producer group, Project I.D. HL-1997-00509 - Carcinogenicity study in rats via the feed, Washington DC, USA 1997
23. Greim, D., G. Lehnert (Hrsg.): N-Methyl-2-pyrrolidon (Dampf). Maximale Arbeitsplatzkonzentrationen. Arbeitsmedizinisch-toxikologische Begründungen. Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Deutsche Forschungsgemeinschaft. 20. Lieferung, Wiley-VCH, Weinheim 1994
24. e trimestre 1997
25. HSE (Health and Safety Executive): N-Methyl-2-pyrrolidone. Risk assessment document. EH72/10, ISBN 0717615286, HSE Books, Sudbury, UK 1997
26. Huntingdon Life Science: unpublished data for the NMP producer group, Project I.D. No. 97-4106, 2-generation study in rats via the feed, Washington DC, USA 1999
27. Jönsson, B. A. G., B. Åkesson: Determination of N-methylsuccinimide and 2-hydroxy-N-methylsuccinimide in human urine and plasma. J. Chrom. B 704 (1997b) 151-158
28. Jönsson, B. A. G., B. Åkesson: Determination of 5-hydroxy-N-methylpyrrolidone and 2-hydroxy-N-methylsuccinimide in human urine. J. Chrom. B 694 (1997a) 351-357
29. Jönsson, B. A. G., B. Åkesson: N-Methylsuccinimide in plasma and urine as a biomarker of exposure to N-methyl-2-pyrrolidine. Int. Arch. Occup. Environ. Health 74 (2001) 289-294
30. Langworth, S., H. Anundi, L. Friis, G. Johanson, M. L. Lind, E. Söderman, B. Åkesson: Acute health effects common during graffiti removal. Int. Arch. Occup. Environ. Health 74 (2001) 213-218
31. Lee, K. P., N. C. Chromey, R. Culik, J. R. Barnes, P. W. Schneider: Toxicity of N-methyl-2-pyrrolidone (NMP): teratogenic, subchronic, and two-year inhalation studies. Fundam. Appl. Toxicol. 9 (1987) 222-235
32. Leira, H. L., A. Tiltnes, K. Svendsen, L. Vetlesen: Irritant cutaneous reactions to N-methyl-2-pyrrolidone (NMP). Contact Dermatitis 27 (1992) 148-150
33. Malek, D. E., L. A. Malley, T. W. Slone, G. S. Elliott, G. L. Kennedy, W. Mellert, K. Deckardt, C. Gembardt, B. Hildebrandt, S. R. Murphy, D. B. Bower, G. A. Wright: Repeated dose toxicity study (28 days) in rats and mice with N-methylpyrrolidone (NMP). Drug Chem. Toxicol. 20 (1997) 63-77
34. Malley, L. A., G. L. Kennedy, G. S. Elliott, T. W. Slone, W. Mellert, K. Deckardt, C. Gembardt, B. Hildebrand, R. J. Parod, T. J. McCarthy, J. C. Griffiths: 90-day subchronic toxicity study in rats and mice fed N-methylpyrrolidone (NMP) including neurotoxicity evaluation in rats. Drug Chem. Toxicol. 22 (1999) 455-480
35. OECD (Organisation for Economic Co-operation and Development): The 2000 OECD List of High Production Volume Chemicals. OECD Environment Directorate, Environment, Health and Safety Division, Paris 2001
36. Priborsky, J., K. Takayama, T. Nagai, D. Waitzova, J. Elis, Y. Makino, Y. Suzuki: Comparison of penetration-enhancing ability of laurocapram, N-methyl-2-pyrrolidone and dodecyl-L- pyroglutamate. Pharma. Weekbl. Sci. Ed. 10 (1988) 189-192
37. Solomon, G. M., E. P. Morse, M. J. Garbo, D. K. Milton: Stillbirth after occupational exposure to N-Methyl-2-pyrrolidone. A case report and review of the literature. J. Occup. Environ. Med. 38 (1996) 705-713 and 39 (1997) 394
38. SRI: Chemical Economics Handbook, 611.5030Q-611.5030U, SRI International, Menlo Park, CA, USA 1995
39. th Edition, Electronic Release, Wiley-VCH Verlag GmbH, Weinheim 2001
40. USITC (United States International Trade Commission) Synthetic Organic Chemicals. United States Production and Sales, USITC Publication 2933, Investigation No. 332-135, USITC, Washington, DC 20436, 1994
41. Wells, D. A., A. A. Hawi, G. A. Digenis: Isolation and identification of the major urinary metabolite of N-methylpyrrolidone in the rat. Drug Metab. Dispos. 20 (1992) 124-126
42. 14C] N-methyl-2-pyrrolidone in the rat. Drug Metab. Dispos. 16 (1988) 243-249